» Articles » PMID: 32838230

SARS-CoV-2 Infection in Pregnancy: A Systematic Review and Meta-analysis of Clinical Features and Pregnancy Outcomes

Overview
Specialty General Medicine
Date 2020 Aug 25
PMID 32838230
Citations 176
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Perform a systematic review and meta-analysis of SARS-CoV-2 infection and pregnancy.

Methods: Databases (Medline, Embase, Clinicaltrials.gov, Cochrane Library) were searched electronically on 6th April and updated regularly until 8th June 2020. Reports of pregnant women with reverse transcription PCR (RT-PCR) confirmed COVID-19 were included. Meta-analytical proportion summaries and meta-regression analyses for key clinical outcomes are provided.

Findings: 86 studies were included, 17 studies (2567 pregnancies) in the quantitative synthesis; other small case series and case reports were used to extract rarely-reported events and outcome. Most women (73.9%) were in the third trimester; 52.4% have delivered, half by caesarean section (48.3%). The proportion of Black, Asian or minority ethnic group membership (50.8%); obesity (38.2%), and chronic co-morbidities (32.5%) were high. The most commonly reported clinical symptoms were fever (63.3%), cough (71.4%) and dyspnoea (34.4%). The commonest laboratory abnormalities were raised CRP or procalcitonin (54.0%), lymphopenia (34.2%) and elevated transaminases (16.0%). Preterm birth before 37 weeks' gestation was common (21.8%), usually medically-indicated (18.4%). Maternal intensive care unit admission was required in 7.0%, with intubation in 3.4%. Maternal mortality was uncommon (~1%). Maternal intensive care admission was higher in cohorts with higher rates of co-morbidities (beta=0.007, p<0.05) and maternal age over 35 years (beta=0.007, p<0.01). Maternal mortality was higher in cohorts with higher rates of antiviral drug use (beta=0.03, p<0.001), likely due to residual confounding. Neonatal nasopharyngeal swab RT-PCR was positive in 1.4%.

Interpretation: The risk of iatrogenic preterm birth and caesarean delivery was increased. The available evidence is reassuring, suggesting that maternal morbidity is similar to that of women of reproductive age. Vertical transmission of the virus probably occurs, albeit in a small proportion of cases.

Funding: N/A.

Citing Articles

Maternal and Fetal Outcomes of COVID-19 According to the Trimester of Diagnosis: A Cross-Sectional Prospective Study in a Tertiary University Hospital.

Al-Husban N, Dibas R, Karadsheh S, Alananzeh L, Aolymat I, Kilani A J Clin Med. 2024; 13(17).

PMID: 39274474 PMC: 11396355. DOI: 10.3390/jcm13175262.


SARS-CoV-2 in Pregnancy, Birth and Puerperium. Guideline of the DGGG and DGPM (S2k-Level, AWMF Registry Number 015/092, March 2022).

Pecks U, Agel L, Doubek K, Hagenbeck C, Jennewein L, von Kaisenberg C Geburtshilfe Frauenheilkd. 2024; 83(5):517-546.

PMID: 39258218 PMC: 11384259. DOI: 10.1055/a-2003-5983.


COVID testing hesitancy among pregnant patients: lessons learned from the COVID-19 pandemic about the unique needs and challenges of medically complex populations.

Farrell R, Dahler C, Pope R, Divoky E, Collart C BMC Pregnancy Childbirth. 2024; 24(1):593.

PMID: 39256689 PMC: 11384699. DOI: 10.1186/s12884-024-06739-x.


The Impact of COVID-19 during Pregnancy on Maternal Hemodynamic Function, Angiogenic Markers and Neonatal Outcome.

Schirwani-Hartl N, Tschanun L, Palmrich P, Haberl C, Perkmann-Nagele N, Kiss H Viruses. 2024; 16(6).

PMID: 38932160 PMC: 11209264. DOI: 10.3390/v16060868.


Pregnancy and COVID-19 - liver damage.

Tofan-Scutaru L, Tcaciuc E, Turcan S Med Pharm Rep. 2024; 94(Suppl No 3):S22-S33.

PMID: 38912402 PMC: 11188027. DOI: 10.15386/mpr-2514.


References
1.
Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M . Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020; 2(2):100107. PMC: 7104131. DOI: 10.1016/j.ajogmf.2020.100107. View

2.
Liao X, Yang H, Kong J, Yang H . Chest CT Findings in a Pregnant Patient with 2019 Novel Coronavirus Disease. Balkan Med J. 2020; 37(4):226-228. PMC: 7285659. DOI: 10.4274/balkanmedj.galenos.2020.2020.3.89. View

3.
Savasi V, Parisi F, Patane L, Ferrazzi E, Frigerio L, Pellegrino A . Clinical Findings and Disease Severity in Hospitalized Pregnant Women With Coronavirus Disease 2019 (COVID-19). Obstet Gynecol. 2020; 136(2):252-258. DOI: 10.1097/AOG.0000000000003979. View

4.
Zambrano L, Fuentes-Barahona I, Bejarano-Torres D, Bustillo C, Gonzales G, Vallecillo-Chinchilla G . A pregnant woman with COVID-19 in Central America. Travel Med Infect Dis. 2020; 36:101639. PMC: 7271224. DOI: 10.1016/j.tmaid.2020.101639. View

5.
Lowe B, Bopp B . COVID-19 vaginal delivery - A case report. Aust N Z J Obstet Gynaecol. 2020; 60(3):465-466. PMC: 7262173. DOI: 10.1111/ajo.13173. View